Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment

J Antimicrob Chemother. 2013 Dec;68(12):2960-3. doi: 10.1093/jac/dkt264. Epub 2013 Jun 27.
No abstract available

Keywords: biomarkers; bone; comorbidities; hormones.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anti-Retroviral Agents / therapeutic use*
  • Biomarkers / blood*
  • Cardiovascular Diseases / epidemiology*
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / blood*
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Osteocalcin / blood*
  • Plasma / chemistry
  • Prognosis
  • Risk Assessment

Substances

  • Anti-Retroviral Agents
  • Biomarkers
  • Osteocalcin
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23